CN1182068A - 对映体混合物的分离方法 - Google Patents

对映体混合物的分离方法 Download PDF

Info

Publication number
CN1182068A
CN1182068A CN97122879A CN97122879A CN1182068A CN 1182068 A CN1182068 A CN 1182068A CN 97122879 A CN97122879 A CN 97122879A CN 97122879 A CN97122879 A CN 97122879A CN 1182068 A CN1182068 A CN 1182068A
Authority
CN
China
Prior art keywords
mixture
acid
pea
optically
resolving agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97122879A
Other languages
English (en)
Chinese (zh)
Inventor
T·R·维里斯
H·维恩堡
E·范厄滕
L·A·胡尔索夫
Q·B·布罗比克兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke DSM NV
Original Assignee
DSM NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM NV filed Critical DSM NV
Publication of CN1182068A publication Critical patent/CN1182068A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/023Preparation; Separation; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/80Preparation of compounds containing amino groups bound to a carbon skeleton by photochemical reactions; by using free radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/34Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
CN97122879A 1996-10-23 1997-10-23 对映体混合物的分离方法 Pending CN1182068A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1004346 1996-10-23
NL1004346A NL1004346C2 (nl) 1996-10-23 1996-10-23 Werkwijze voor het scheiden van een mengsel van enantiomeren in een geschikt oplosmiddel.

Publications (1)

Publication Number Publication Date
CN1182068A true CN1182068A (zh) 1998-05-20

Family

ID=19763731

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97122879A Pending CN1182068A (zh) 1996-10-23 1997-10-23 对映体混合物的分离方法

Country Status (11)

Country Link
US (1) US6235927B1 (https=)
EP (1) EP0838448B1 (https=)
JP (1) JPH10245368A (https=)
CN (1) CN1182068A (https=)
AT (1) ATE264826T1 (https=)
CA (1) CA2218804A1 (https=)
DE (1) DE69728730T9 (https=)
IL (1) IL122012A (https=)
IN (1) IN184142B (https=)
NL (1) NL1004346C2 (https=)
NO (1) NO974779L (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101792398A (zh) * 2010-03-09 2010-08-04 河北科技大学 一种拆分法制备光学纯对羟基苯甘氨酸的方法
CN102112425A (zh) * 2008-07-29 2011-06-29 普克塞尔公司 通过控制粒径的结晶从对映体混合物中分离对映体组分的方法
CN104829459A (zh) * 2015-05-06 2015-08-12 河北凯力昂生物科技有限公司 一种拆分法制备(r)-(+)-1-萘乙胺的方法
CN104876856A (zh) * 2015-05-05 2015-09-02 河北凯力昂生物科技有限公司 一种拆分法制备(r)-(+)-3-氨基哌啶二盐酸盐的方法
CN108658784A (zh) * 2018-04-26 2018-10-16 联化科技股份有限公司 (r)-1-(4-甲基苯基)乙胺的合成方法
CN109485561A (zh) * 2018-11-23 2019-03-19 江苏颖盛化工有限公司 一种dl-萘普生的合成工艺

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042460A1 (en) * 1998-02-20 1999-08-26 Fine Chemicals Corporation (Proprietary) Limited Process for the production of optically enriched (r)- or (s)-albuterol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
NL1008911C2 (nl) * 1998-04-17 1999-10-19 Dsm Nv Werkwijze voor het verhogen van de enantiomere overmaat van een chirale verbinding.
EP1034826A1 (en) 1999-03-05 2000-09-13 Reuter Chemische Apparatebau Co-crystallization process
NL1012865C2 (nl) * 1999-08-19 2001-02-20 Dsm Nv 1-Fenyl-3-oxopropaan-1-sulfonzuren en -sulfonaten en zuivere enantiomeren daarvan.
WO2001030763A1 (en) * 1999-10-22 2001-05-03 Takeda Chemical Industries, Ltd. Process for producing optically active naphthalene derivative and optical resolver therefor
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
JP2005104895A (ja) * 2003-09-30 2005-04-21 Nippon Kayaku Co Ltd 光学活性なアミノアルコール化合物の製造法
ATE361905T1 (de) * 2003-12-10 2007-06-15 Degussa Verfahren zur herstellung von enantiomeren angereicherten aminosäuren
EP1720861A2 (en) 2004-02-25 2006-11-15 Eli Lilly And Company Histamine h3 receptor antagonists, preparation and therapeutic uses
WO2006006071A1 (en) * 2004-07-07 2006-01-19 Pfizer Products Inc. Resolution of an aryl-fused azapolycyclic compound
EP1885692A2 (en) * 2005-05-04 2008-02-13 Medichem, S.A. Process for the preparation of tamsulosin
MX2007016216A (es) 2005-07-01 2008-03-11 Lilly Co Eli Agenes del receptor de histamina h3, preparacion y usos terapeuticos.
ES2393757T3 (es) 2005-11-17 2012-12-27 Eli Lilly & Company Antagonistas de receptor de glucagón, preparación y usos terapéuticos
WO2007114855A2 (en) 2005-11-18 2007-10-11 Eli Lilly And Company Glucagon receptor antagonists, preparation and therapeutic uses
UA99284C2 (ru) 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR075988A1 (es) 2009-04-09 2011-05-11 Lilly Co Eli Compuesto de piridiloxi - pirrolidina inhibidor de recaptacion de serotonina y norepinefrina, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de dolor cronico
EA020151B1 (ru) 2009-10-23 2014-09-30 Эли Лилли Энд Компани Ингибиторы akt и фармацевтические составы, их содержащие
KR102565407B1 (ko) * 2016-01-04 2023-08-10 (주)아모레퍼시픽 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
WO2021074778A1 (en) * 2019-10-16 2021-04-22 Hikal Limited An industrial process for resolution of chlocyphos
US20260015329A1 (en) * 2022-07-14 2026-01-15 Kureha Corporation Method for producing triazole derivative enantiomer (r)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB656500A (en) * 1947-10-24 1951-08-22 Sterling Drug Inc Improvements in or relating to the preparation of l-arterenol and l-arterenol so prepared
US3862985A (en) * 1971-07-28 1975-01-28 Allied Chem Resolution of lysineamide
WO1985003932A1 (en) * 1984-03-01 1985-09-12 Alkaloida Vegyészeti Gyár Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102112425A (zh) * 2008-07-29 2011-06-29 普克塞尔公司 通过控制粒径的结晶从对映体混合物中分离对映体组分的方法
CN102112425B (zh) * 2008-07-29 2014-06-11 普克塞尔公司 通过控制粒径的结晶从对映体混合物中分离对映体组分的方法
CN101792398A (zh) * 2010-03-09 2010-08-04 河北科技大学 一种拆分法制备光学纯对羟基苯甘氨酸的方法
CN101792398B (zh) * 2010-03-09 2013-06-26 河北科技大学 一种拆分法制备光学纯对羟基苯甘氨酸的方法
CN104876856A (zh) * 2015-05-05 2015-09-02 河北凯力昂生物科技有限公司 一种拆分法制备(r)-(+)-3-氨基哌啶二盐酸盐的方法
CN104876856B (zh) * 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法
CN104829459A (zh) * 2015-05-06 2015-08-12 河北凯力昂生物科技有限公司 一种拆分法制备(r)-(+)-1-萘乙胺的方法
CN108658784A (zh) * 2018-04-26 2018-10-16 联化科技股份有限公司 (r)-1-(4-甲基苯基)乙胺的合成方法
CN108658784B (zh) * 2018-04-26 2020-12-18 联化科技股份有限公司 (r)-1-(4-甲基苯基)乙胺的合成方法
CN109485561A (zh) * 2018-11-23 2019-03-19 江苏颖盛化工有限公司 一种dl-萘普生的合成工艺

Also Published As

Publication number Publication date
NL1004346C2 (nl) 1998-04-24
CA2218804A1 (en) 1998-04-23
ATE264826T1 (de) 2004-05-15
DE69728730D1 (de) 2004-05-27
EP0838448B1 (en) 2004-04-21
IL122012A (en) 2001-08-26
US6235927B1 (en) 2001-05-22
IN184142B (https=) 2000-06-17
JPH10245368A (ja) 1998-09-14
DE69728730T9 (de) 2005-09-08
NO974779L (no) 1998-04-24
DE69728730T2 (de) 2005-03-31
IL122012A0 (en) 1998-03-10
NO974779D0 (no) 1997-10-16
EP0838448A1 (en) 1998-04-29

Similar Documents

Publication Publication Date Title
CN1182068A (zh) 对映体混合物的分离方法
Fogassy et al. Optical resolution methods
EP0057092B1 (en) Process for racemizing an optically active alpha-amino acid or a salt thereof
CN1095069A (zh) 制备和/或纯化棒酸或其药用盐或其酯的新方法
CN1053669C (zh) 由外消旋物拆分制备[l]-或[d]-高丙氨酸-4-基-(甲基)膦酸和其盐的方法
KR100393133B1 (ko) 레보부피바카인및그의유사체의제조에사용하는라세미화및비대칭변환방법
CN1102561C (zh) 外消旋体的拆分
CN1286820C (zh) 4-烷氧基-环己烷-1-氨基-羧酸酯及其生产方法
EP3374345B1 (en) Processes for the preparation of diastereomerically and enantiomerically enriched oxazolines
CN1550500A (zh) 制备(1s,4r)-或(1r,4s)-4-(2-氨基-6-氯-9-h-嘌呤-9-基)-2-环戊烯基-1-甲醇或其盐的方法
CN1440379A (zh) (r)-2-烷基-3-苯基丙酸的制备
CN1473145A (zh) 氨基酸衍生物的光学异构体的分离方法
Yokomatsu et al. Enzymatic desymmetrization of prochiral 2-benzyl-1, 3-propanediol derivatives: A practical chemoenzymatic synthesis of novel phosphorylated tyrosine analogues
WO2017118928A1 (en) Process for the separation of diastereomers of tenofovir alafenamide
CN1082046C (zh) 2-(2-羟甲基苯基)乙酰胺衍生物的制备方法及其制备用中间体
CN1015172B (zh) 卤化-3-卤代-2-羟基丙基三甲基铵的制备方法
CN1886359A (zh) 通过与手性碱环酰胺形成盐而拆分任选取代的扁桃酸的方法
CN1174201A (zh) 新的天冬氨酰基二肽酰胺衍生物和增甜剂
CN1083425C (zh) 由环氧化物制备顺式-1-氨基-2-链烷醇的区域专一性方法
US6465684B2 (en) Process for the separation of a mixture of enantiomers
CN1441771A (zh) 生产3,3-二芳基丙基胺的方法
CN1163472C (zh) 用于制备手性氨基酸的新方法
WO2006008171A1 (en) Process for the preparation of a diastereomerically enriched compound
CN1216054C (zh) 1,4-二氢吡啶-3,5-二羧酸衍生物及其制备方法
US20090253932A1 (en) Resolution of Racemic Organic Acids with (1S, 4S)-4[3,4-Dichlorophenyl]-1,2,3,4-Tetrahydro-N-Methyl-1-Naphthaloneamine

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication